Objective: To evaluate the efficacy and safety of Zhumian Tang formula granules combined with eszopiclone for treating poor sleep quality.

Methods: This multi-center, dynamic block-randomized, parallel-group superiority clinical trial included 130 patients. The combined treatment group received Zhumian Tang formula granules combined with eszopiclone treatment, and the control group received eszopiclone treatment only. The group allocation ratio was 1∶1. The duration of treatment was 2 weeks. Participants were asked to complete questionnaires before treatment, after 1 week of the intervention, after 2 weeks of the intervention, and at the follow-up on week 3. The primary outcomes were the Pittsburgh Sleep Quality Index (PSQI) score and the total effective rate of treatment. The secondary outcome was the rate of adverse effects.

Results: Compared with the eszopiclone treatment group, the PSQI score of the combined treatment group was significantly lower after 2 weeks of the intervention (6.98 8.26, 0.05). However, there was no significant difference in the mean PSQI score after 1 week of the intervention (9.89 9.15, 0.124). After the follow-up on week 3, the PSQI score of the combined treatment group remained significantly lower than that of the eszopiclone treatment group (6.12 8.31, 0.001). The total effective rates of treatment of the combined group and the eszopiclone group were 36.92% 35.38% ( 0.033, 0.855) after 1 week of the intervention, 83.08% 58.46% ( 9.519, 0.05) after 2 weeks of the intervention, and 83.08% 61.54% ( 7.530, 0.05) and after the follow-up on week 3, respectively. There was no significant difference in the overall rate of adverse reactions between the combined and eszopiclone treatment groups (21.53% 31.8%, 0.318).

Conclusion: The combination of Zhumian Tang formula granules with eszopiclone was found to be safe and more effective in improving sleep quality than eszopiclone alone. Traditional Chinese medicine can enhance the effectiveness of Western medicine in the treatment of insomnia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774717PMC
http://dx.doi.org/10.19852/j.cnki.jtcm.2024.01.002DOI Listing

Publication Analysis

Top Keywords

eszopiclone treatment
24
treatment group
24
zhumian tang
16
tang formula
16
formula granules
16
combined eszopiclone
16
psqi score
16
treatment
14
granules combined
12
sleep quality
12

Similar Publications

Effects of Approved Pharmacological Interventions for Insomnia on Mood Disorders: A Systematic Review.

Clin Neuropsychiatry

October 2024

Department of Surgical, Medical and Molecular Pathology, Critical and Care Medicine, University of Pisa, Pisa, Italy, Department of Neuroscience, Azienda Ospedaliera Universitaria Pisana (AUOP), Pisa, Italy.

Objective: Insomnia can be a contributing factor, a comorbid disorder, or a transdiagnostic element to several mental disorders, including mood disorders (MDs). A recent meta-analysis has already shown the effectiveness of cognitive behavioral treatment (CBT) for insomnia that is comorbid with MDs. This work aimed to systematically review data on pharmacological insomnia treatment in the context of MDS.

View Article and Find Full Text PDF
Article Synopsis
  • * It reviews pharmacological treatments for common sleep issues like REM sleep behavior disorder (RBD), excessive daytime sleepiness (EDS), insomnia, and restless legs syndrome (RLS), emphasizing the use of melatonin, clonazepam, modafinil, and caffeine.
  • * The article suggests that optimizing dopaminergic treatments at night and maintaining good sleep hygiene can improve sleep quality, but more evidence is needed to widely recommend some of the therapies mentioned.
View Article and Find Full Text PDF

Introduction: Acetazolamide, eszopiclone, and venlafaxine may target different underlying mechanisms of obstructive sleep apnea (OSA) and individually may partially improve OSA severity in select patients. We tested whether acetazolamide+eszopiclone (DualRx) improves OSA severity. We further explored whether addition of venlafaxine (TripleRx) improves OSA in patients who do not fully respond to DualRx.

View Article and Find Full Text PDF

Objective: This study aimed to investigate the efficacy of mindfulness meditation on sleep quality and negative emotions in patients with stroke with concurrent coronary heart disease.

Methods: This study was a randomised controlled trial. A total of 72 patients with stroke with concurrent coronary heart disease were randomly divided into an observation group and a control group, with 36 patients in each group.

View Article and Find Full Text PDF

Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt.

BMC Gastroenterol

October 2024

Department of Gastroenterology and Hepatology, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Article Synopsis
  • * Minimal hepatic encephalopathy (MHE) was identified as a significant risk factor for developing SD after TIPS, with a higher prevalence in affected patients compared to those without SD (58% vs. 31%).
  • * Treatment with eszopiclone helped improve sleep quality in 83% of patients who received it, while 77% of patients experienced spontaneous improvement without treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!